1,1'-Carbonyldiimidazole | CAS:530-62-1
1,1'-Carbonyldiimidazole
- 名称:N,N'-羰基二咪唑 | 1,1'-Carbonyldiimidazole
- CAS号:530-62-1
- 别名:1,1'-Carbonylbis-1H-imidazole; N,N'-Carbonyldiimidazole; CDI
- 分子式:C7H6N4O
- 分子量:162.15
- EINESC号:208-488-9
产品描述
物理化学性质
熔点 | 118-120 ºC |
---|
安全数据
危险品标志 | Xi |
---|---|
危险类别码 | R36/37/38 |
安全说明书 | S26;S37/39 |
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
更多
文章
同行评议文献
A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain.Susan L McElroy et al.Journal of clinical psychopharmacology, 32(2), 165-172 (2012-03-01)
Zonisamide: no magic bullet.Mitchell H Katz Archives of internal medicine, 172(20), 1565-1565 (2012-10-17)
Management and monitoring of patients treated with zonisamide: the OZONE study.Sophie Dupont et al.Epileptic disorders : international epilepsy journal with videotape, 15(3), 278-288 (2013-08-03)
Zonisamide monotherapy for idiopathic epilepsy in dogs.J Y Chung et al.New Zealand veterinary journal, 60(6), 357-359 (2012-05-30)
Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients.Dong Wook Kim et al.Epilepsy & behavior : E&B, 23(4), 497-499 (2012-03-24)
Risk factors for hyperammonemia in pediatric patients with epilepsy.Yoshiaki Yamamoto et al.Epilepsia, 54(6), 983-989 (2013-02-16)
Upregulated and Hyperactivated Thalamic Connexin 43 Plays Important Roles in Pathomechanisms of Cognitive Impairment and Seizure of Autosomal Dominant Sleep-Related Hypermotor Epilepsy with S284L-Mutant α4 Subunit of Nicotinic ACh Receptor.Kouji Fukuyama et al.Pharmaceuticals (Basel, Switzerland), 13(5) (2020-05-24)
Zonisamide attenuates MPP+-induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells.Vedat Ali Yürekli et al.Cellular and molecular neurobiology, 33(2), 205-212 (2012-12-12)
Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial.Kishore M Gadde et al.Archives of internal medicine, 172(20), 1557-1564 (2012-11-14)
Application of surfactant assisted dispersive liquid-liquid microextraction as an efficient sample treatment technique for preconcentration and trace detection of zonisamide and carbamazepine in urine and plasma samples.Mohammad Behbahani et al.Journal of chromatography. A, 1308, 25-31 (2013-08-21)
[Bilateral urolithiasis with zonisamide developed for a short period of time in a 10-year-old girl with intractable epilepsy].Shunsuke Sato et al.Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 104(5), 674-677 (2013-11-06)
Impact of antiepileptic drugs on genesis of psychosis.Takahiro Noguchi et al.Epilepsy & behavior : E&B, 23(4), 462-465 (2012-03-13)
Partial epilepsy and developmental delay in infant with ring chromosome 14.G Imataka et al.Genetic counseling (Geneva, Switzerland), 24(1), 81-83 (2013-04-25)
Another option for first-line treatment of partial epilepsy?Bassel W Abou-Khalil The Lancet. Neurology, 11(7), 568-569 (2012-06-12)
Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide.J Antel et al.Handbook of experimental pharmacology, (209)(209), 433-466 (2012-01-18)
Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial.Yusuke Iwata et al.Journal of the neurological sciences, 315(1-2), 137-140 (2012-01-31)
Partial epilepsy and developmental delay in infant with ring chromosome 14.G Imataka et al.Genetic counseling (Geneva, Switzerland), 24(1), 81-83 (2013-04-25)
Combination therapy of zonisamide with aripiprazole on ECT- and benzodiazepine-resistant periodic catatonia.Masanori Nakagawa et al.The Journal of neuropsychiatry and clinical neurosciences, 24(3), E9-E9 (2012-10-06)
Antiepileptic drugs as prophylaxis for post-craniotomy seizures.Jennifer Pulman et al.The Cochrane database of systematic reviews, 2(2), CD007286-CD007286 (2013-03-02)
Latest advancements in the pharmacological treatment of binge eating disorder.D Marazziti et al.European review for medical and pharmacological sciences, 16(15), 2102-2107 (2013-01-03)
Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors.M E Choudhury et al.European journal of pharmacology, 689(1-3), 72-80 (2012-06-05)
Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: a multicenter open-label single-arm trial in Korean patients.Kyoung Heo et al.Seizure, 21(3), 188-193 (2012-01-10)
Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease.Yuto Ueda et al.Biochemical and biophysical research communications, 428(3), 401-404 (2012-10-30)
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study.Andrea Romigi et al.Epilepsy & behavior : E&B, 26(2), 170-174 (2013-01-15)
Effects of Carbamazepine, Lacosamide and Zonisamide on Gliotransmitter Release Associated with Activated Astroglial Hemichannels.Kouji Fukuyama et al.Pharmaceuticals (Basel, Switzerland), 13(6) (2020-06-11)
Zonisamide in clinical practice.S Dupont et al.Acta neurologica Scandinavica. Supplementum, (194)(194), 29-35 (2012-11-01)
Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial.Renzo Guerrini et al.Epilepsia, 55(4), 568-578 (2014-03-14)
Actigraphic study of tremor before and after treatment with zonisamide in patients with Parkinson's disease.Soichiro Mochio et al.Parkinsonism & related disorders, 18(7), 906-908 (2012-05-02)
Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.Michel Baulac et al.The Lancet. Neurology, 11(7), 579-588 (2012-06-12)
Zonisamide: its pharmacology, efficacy and safety in clinical trials.M J Brodie et al.Acta neurologica Scandinavica. Supplementum, (194)(194), 19-28 (2012-11-01)
Zonisamide for the treatment of self-inflicted dermatoses related to impulse control disorders.Maria José Tribó et al.Archives of dermatology, 148(6), 762-764 (2012-06-20)
Zonisamide: Antihyperalgesic efficacy, the role of serotonergic receptors on efficacy in a rat model for painful diabetic neuropathy.Nurcan Bektas et al.Life sciences, 95(1), 9-13 (2013-12-24)
[Epilepsy in the elderly].Karl O Nakken et al.Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 133(5), 528-531 (2013-03-07)
Zonisamide in the treatment of bulimia nervosa: an open-label, pilot, prospective study.Anna I Guerdjikova et al.The International journal of eating disorders, 46(7), 747-750 (2013-07-31)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
RelatedAPI's
名称 | CAS号 | |
---|---|---|
Imidazole | 288-32-4 | 查看 |
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!